Skip to main content

What the FDA labels say about taking them together

Digoxin and perindopril

Perindopril's FDA label of March 13, 2024 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name perindopril. The perindopril label: “Digoxin A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with perindopril erbumine, but an effect of digoxin on the plasma concentration of …”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the perindopril FDA label on DailyMed (effective March 13, 2024, Aurobindo Pharma Limited).

What does the digoxin label say about perindopril?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name perindopril in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the perindopril label say about digoxin?

Perindopril label, drug interactions

Digoxin A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with perindopril erbumine, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.

Source: FDA drug label (Perindopril Erbumine), Aurobindo Pharma Limited, effective March 13, 2024 (SPL set 87768fbf-7c63-47da-8925-0316f343d6ef), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
1Perindopril generic labelers
DigoxinPerindopril
Labeled forHeart failure, Atrial fibrillationHigh blood pressure, Heart attack and coronary artery disease
Boxed warningNoYes
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$0.495 per tablet 4 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?